Lapband

The LAP-BAND® Adjustable Gastric Banding System is the first U.S. Food and Drug Administration (FDA) approved adjustable gastric band for use in weight reduction. Used in more than 300,000 procedures worldwide, this simple reversible surgically implanted device has safely helped severely obese adults successfully achieve and maintain long-term weight loss. The LAP-BAND® System was approved by the FDA in June 2001 for severely obese adults with a Body Mass Index (BMI) of 40 or more or for adults with a BMI of at least 35 plus at least one severe obesity-related health condition, such as Type 2 diabetes, hypertension and asthma.

How the LAP-BAND® Adjustable Gastric Banding System Works:

The LAP-BAND® System was developed to facilitate long-term weight loss and reduce the health risks associated with severe and morbid obesity. Unlike gastric bypass, it does not involve stomach cutting, stapling or intestinal re-routing. , , Using laparoscopic surgical techniques, the device is placed around the top portion of the patient’s stomach, creating a small pouch. By reducing stomach capacity, the LAP-BAND® System can help achieve long-term weight loss by creating an earlier feeling of satiety. The LAP-BAND® System is adjustable, which means that the inflatable band can be tightened or loosened to help the patient achieve a level of satiety while maintaining a healthy diet. It is also reversible and can be removed at any time.

Key Benefits of the LAP-BAND®System over Gastric Bypass:

LAP-BAND®System Effectiveness:

© 2007 Allergan, Inc. Irvine, CA 92612. ® and ™ marks owned by Allergan, Inc.
Chapman A, Game P, O’Brien P, Maddern G, Kiroff G, Foster B, Ham J. Executive summary: Laparoscopic adjustable gastric banding for the treatment of obesity: Update and re-appraisal. Australian Safety and Efficacy Register of New Interventional Procedures-Surgical (ASERNIP-S) Report No. 31, Second Edition. Adelaide, South Australia: ASERNIP-S, June 2002. (Laparoscopic adjustable gastric banding surgery, like the LAP-BAND® surgery, is associated with a mean short-term mortality rate of around 0.05% compared to 0.50% for Gastric Bypass and 0.31% for Vertical Banded Gastroplasty.)
Parikh MS, Shen R, Weiner M, Siegel N, Ren CJ. Laparoscopic bariatric surgery in super-obese patients (BMI>50) is safe and effective: a review of 332 patients. Obes Surg. 2005 Jun-Jul;15(6):858-63.
Chapman AE, Kiroff G, Game P, Foster B, O’Brien P, Ham J, Maddern GJ. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 2004;135:326-351.
Fisher BL, Schauer P.Medical and surgical options in the treatment of severe obesity. Am J Surg 2002;184:9S-16S.
Ahroni JH, Montgomery KF, Watkins BM. Laparoscopic Adjustable Gastric Banding: Weight Loss, Co-morbidities, Medication Usage and Quality of Life at One Year,” Obesity Surgery 2005; 15:641-647.